» Articles » PMID: 20967865

Surgical Salvage of Persistent or Recurrent Nasopharyngeal Carcinoma with Maxillary Swing Approach - Critical Appraisal After 2 Decades

Overview
Journal Head Neck
Date 2010 Oct 23
PMID 20967865
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The purpose of this study was to report on our experience on salvage nasopharyngectomy using the maxillary swing approach for persistent or recurrent nasopharyngeal carcinoma after primary treatment.

Methods: Over the past 2 decades, we have performed salvage nasopharyngectomies for 246 patients. Thirty-seven patients (15%) had persistent disease and 209 (85%) had recurrent tumors.

Results: All patients survived the operation with minimal morbidity. Negative resection margins were achieved in 191 patients (78%), and 55 patients (22%) had microscopic residual disease. The median follow-up was 38 months. The 5-year actuarial control of disease in the nasopharynx was 74%. The 5-year disease-free survival was 56%. Cox regression model identified the negative resection margin and the size of the tumor as 2 independent factors that affected local control of disease and survival.

Conclusion: Maxillary swing nasopharyngectomy is an effective salvage procedure for a small, persistent, or recurrent tumor in the nasopharynx after primary therapy.

Citing Articles

Salvage Endoscopic Nasopharyngectomy for Recurrent Nasopharyngeal Cancer: an Institutional Experience.

Eroglu E, Pamuk A, Ozer S, Onerci T Turk Arch Otorhinolaryngol. 2024; 62(2):42-47.

PMID: 39463065 PMC: 11572336. DOI: 10.4274/tao.2024.2024-1-2.


Toripalimab plus capecitabine in the treatment of patients with residual nasopharyngeal carcinoma: a single-arm phase 2 trial.

Cao X, Huang H, Liang C, Lin Z, Zhou J, Chen X Nat Commun. 2024; 15(1):949.

PMID: 38297016 PMC: 10831082. DOI: 10.1038/s41467-024-45276-1.


Diagnostic Value of Dynamic F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (F-FDG PET-CT) in Cervical Lymph Node Metastasis of Nasopharyngeal Cancer.

Li G, Yang S, Wang S, Jiang R, Xu X Diagnostics (Basel). 2023; 13(15).

PMID: 37568893 PMC: 10417831. DOI: 10.3390/diagnostics13152530.


Treatment of intractable epistaxis in patients with nasopharyngeal cancer.

Yang X, Ren H, Li M, Zhu Y, Zhang W, Fu J Ann Med. 2023; 55(1):2200257.

PMID: 37074291 PMC: 10120450. DOI: 10.1080/07853890.2023.2200257.


Schwannoma Arising in Nasopharynx: A Case Report and Literature Review.

Tanjararak K, Tangbumrungtham N, Plumworasawat S, Roongpuvapaht B Indian J Otolaryngol Head Neck Surg. 2022; 74(Suppl 2):911-917.

PMID: 36452824 PMC: 9702495. DOI: 10.1007/s12070-020-02000-x.